1, Shenzhen Weiguang Biological Products Co., Ltd. was registered on April 07, 1986 in the Shenzhen Municipal Market Supervision Administration Guangming Bureau. Legal representative Wang Jincai, the company's scope of business includes drug research and development. Production and operation of blood products (human albumin large-volume injection, human albumin small-volume injection, human albumin lyophilized powder injection, human immunoglobulin lyophilized powder injection, histamine human immunoglobulin lyophilized powder injection, specific human immunoglobulin lyophilized powder injection, specific human immunoglobulin small-volume injection, lyophilized human immunoglobulin injection (PH4), human immunoglobulin injection (PH4) ), human immunoglobulin, human fibrinogen), etc.
2, Shenzhen Weiguang Biological Products Co., Ltd. (stock code: 002880) was founded in 1985, is located in Shenzhen Guangming District, state-owned enterprises, high-tech enterprises, the first batch of blood products enterprises in Shenzhen, its nine subsidiaries, distributed in Guangdong Province, Guangxi Province and Hainan Province, the sales area of the global radiation. Mainly engaged in blood products, vaccines, diagnostic reagents and recombinant products research and development, production and sales, the company by virtue of strong R & D strength, leading technology, first-class production and testing equipment, scientific and standardized management and perfect quality assurance system, is committed to become China's differentiated blood products pioneers and platform for biopharmaceuticals upstarts.
3. Introduction of the Park, Weiguang Life Science Park is located in the core area of science and education of Guangming Science City, Beizhen Road, Guangming District, Shenzhen, and is built and operated by Shenzhen Weiguang Biological Products Co. It covers an area of 66,700 square meters, and the first and second phases have a floor area of about 200,000 square meters. The park focuses on the advanced fields and frontier breakthroughs of global biotechnology, focuses on the middle and late stages of achievement transformation, and actively undertakes the transformation of scientific research achievements of the Guangming Science City, colleges and universities, medical institutions and other research institutions. By building a specialized value-added service platform and a featured technology platform as well as a perfect project management system, the park attracts and cultivates biotechnology projects with high market potential, high technical barriers and leading domestic and international biotechnology projects, accelerates the market application of laboratory research results, and attracts a large number of biomedical start-ups and high-quality projects to settle in Guangming.